State Of The Art Lecture: What Are The Most Important Ongoing Clinical Trials In Urologic Oncology Worldwide?

ORLANDO, FL (UroToday.com) - Dr. E. David Crawford presented information on challenges facing clinical trials from SWOG, ECOG and CALGB. Patient accrual for clinical trials is only 2-3%. Innumerable layers of rules and regulations have been created with numerous layers that increase costs and delays. He applauded prevention trials such as PCPT, SELECT, Toremifene for PIN and REDUCE. He gave poor marks for randomized treatment trials.

More: continued here

Filed under: Cancer on June 30th, 2008